Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-05-04

Clinical Trial Update: Effect of Steroids on Gene Expression in the Healthy Smokers Lungs [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effect of corticosteroids on lung gene expression in the context of chronic obstructive pulmonary disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corticosteroids (steroids) (corticosteroids)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Status: WITHDRAWN